Investing in unprofitable businesses like Corvus Pharmaceuticals can be lucrative, but risky due to potential cash burn issues. Analyzing its cash reserves and cash runway can help shareholders assess financial health and future prospects for growth. Monitoring cash burn trends and ability to raise more funds are key considerations.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing